Table 3.

Effects of Cassia fistula methanolic extract (CFME) on hemodynamic parameters after ISP-induced myocardial necrosis.

Group	AP (mmHg)	SAP (mmHg)	DAP (mmHg)	MAP (mmHg)	HR (per min)
Control	112.502 ± 0.772	126.903 ± 1.321	99.241 ± 0.971	110.722 ± 0.691	399.723 ± 1.732
ISP	95.152 ± 1.911∗	94.543 ± 0.953∗	79.512 ± 0.602∗	90.181 ± 1.413∗	408.112 ± 1.443
CFME-LD per se	110.521 ± 1.382	126.822 ± 1.433	100.723 ± 2.333	111.012 ± 0.981	388.522 ± 2.250
CFME-HD per se	110.721 ± 1.523	129.844 ± 0.803	103.933 ± 1.714	114.521 ± 1.149	392.122 ± 3.851
CFME-LD + ISP	100.722 ± 1.413	94.082 ± 1.772	83.801 ± 0.562	95.101 ± 1.172	405.221 ± 1.773
CFME-HD + ISP	102.443 ± 1.154∗∗	101.021 ± 1.432∗∗∗	86.372 ± 1.322∗∗∗	96.391 ± 2.063∗∗∗	397.344 ± 1.134

ISP: Isoproterenol; CFME-LD: CFME at lower dose (250 mg/kg); CFME-HD: CFME at higher dose (500 mg/kg); AP: arterial pressure; SAP: systolic arterial pressure, DAP: diastolic arterial pressure; MAP: mean arterial pressure; HR: heart rate. Data are expressed as mean value ± S.E.M (n = 7) analyzed using one-way ANOVA followed by Tukey's multiple comparison test. ^∗p < 0.001 when compared to the control group, ^∗∗∗p < 0.05, ^∗∗p < 0.01 when compared to the ISP control group.